<DOC>
	<DOCNO>NCT00676065</DOCNO>
	<brief_summary>The objective study characterize compare risk long-term use oral contraceptive contain drospirenone establish oral contraceptive .</brief_summary>
	<brief_title>Long-term Active Surveillance Study Oral Contraceptives ( LASS )</brief_title>
	<detailed_description>The LASS Study large , multinational , prospective , control , non-interventional , long-term cohort study follow series cohort . The cohort consist new user ( first-ever user , switcher restarters ) three different group oral contraceptive ( OCs ) : OCs contain drospirenone ( DRSP ) , OCs contain levonorgestrel ( LNG ) OCs contain progestogen . A `` non-interference '' approach use provide standardize , comprehensive , reliable information group OCs routine medical condition . The main clinical outcome interest long-term follow-up arterial venous thromboembolism well breast cancer . Regular , active contact cohort member ( =active surveillance ) provide necessary information health-related event change health status . The study base exist long-term EURAS cohort still follow-up . LASS succeed EURAS prolongs follow-up period another five year . Total follow-up time member long-term cohort 6 10 year . By mean annual contact almost relevant clinical outcome capture . This accomplish contact relevant physician review relevant source document case relevant clinical outcome .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Women prescribe oral contraceptive new user ( firstever user , switcher restarters ) formulation Women consent participate study</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Contraception</keyword>
	<keyword>Thromboembolism</keyword>
	<keyword>Breast Cancer</keyword>
</DOC>